BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

BenevolentAI

BenevolentAI logo

Founded
2013
Geography
United Kingdom based
Funding
$292 M

BenevolentAI uses artificial intelligence to mine and analyse biomedical information, from clinical trails data to academic papers.

Benevolent AI can also use the predictive power of its AI algorithm to design new molecules, extracting new hypothesis based on a knowledge graph composed of over a billion relationships between genes, targets, diseases, proteins and drugs. “When the periodic table of the elements was generated, there were gaps in that table where you know elements had to exist, but they hadn't been discovered,” Hunter says. “We use our knowledge graph like that: what relationship should be present but are not yet known?"

Technologies

AI Companies (Drug Discovery)   Pharmaceutical and Drug Discovery  


Posts Mentioning This Company

Video gallery
Biopharma Insights
Biopharma Insights

R&D Platform

Evolved from text mining and semantic linking into knowledge graphs. Recent small efforts into DL and computational chemistry mostly for PR.


The Benevolent Platform

Read more

Pipelines

No pipelines published yet

Products

 

Services

No services posted yet